Krempa David bought ETON
June 26, 2026 · Form 4 insider transaction
Krempa David bought 10,000 shares of Eton Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$0.00
Total value
N/A
InsiderKrempa David
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJune 26, 2026
Filing dateJune 30, 2026
Shares owned after96,829
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.; The restricted stock units vest in four equal annual installments beginning June 26, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.